Since my retirement after working as a neurologist in the USA for over five decades, I have been spending a significant ...

Parkinson’s is the fastest growing neurological disease in the world. More than 110,000 Canadians have the disorder and every ...

Parkinson’s — which can cause tremors, slow movement and stiffness — is believed to affect 1 in every 336 Americans.

Restless legs syndrome has been linked to an increased risk for Parkinson’s disease in new findings that suggest the ...

Precision medicine holds enormous promise in enhancing treatment efficacy and advancing therapeutic development, leading to more equitable care. However, to realise this promise in all individuals ...

Scientists have discovered that mutations in the EPG5 gene—known for causing the rare childhood disorder Vici syndrome—also increase the risk of Parkinson’s disease and dementia later in life.

Three research hospitals in the Republic of Korea are reporting that restless leg syndrome was associated with an increased ...

There’s been a surge in interest — from investors and hospitals alike — in startups developing technologies to monitor and ...

With a flurry of startup activity, tech to monitor the symptoms of Parkinson’s disease is building momentum in care for the ...

Researchers have designed a peptide that prevents the deadly misfolding of alpha-synuclein, the protein behind Parkinson’s ...

Cognitive decline and anxiety in Parkinson's disease are often only recognized at a late stage, yet they can greatly impact people's lives. Research by Marit Ruitenberg focuses on new tests and ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. The ways he does this are ...